Comparative Pharmacology
Head-to-head clinical analysis: PLASMA LYTE 148 IN WATER IN PLASTIC CONTAINER versus PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PLASMA LYTE 148 IN WATER IN PLASTIC CONTAINER versus PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER.
PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER vs PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Plasma-Lyte 148 is an isotonic crystalloid solution that provides electrolyte replacement and volume expansion. It mimics plasma electrolyte composition, with acetate and gluconate as bicarbonate precursors that are metabolized to bicarbonate in the liver and kidneys, helping to maintain acid-base balance.
Plasma-Lyte 56 and Dextrose 5% is a crystalloid solution that provides electrolytes and carbohydrates. Dextrose is metabolized to glucose, which is utilized for cellular energy production. The electrolytes (sodium, chloride, potassium, magnesium, and acetate) maintain or restore intravascular volume, acid-base balance, and osmotic gradients. Acetate is metabolized to bicarbonate, providing an alkalinizing effect.
Intravenous infusion; dose determined by electrolyte and fluid requirements. Typical adult rate: 25-100 mL/hour.
Intravenous infusion; dose depends on fluid and electrolyte requirements. Typical adult dose: 500-1000 mL as a single infusion, rate up to 333 mL/hour. Maximum 3 L/24 hours.
None Documented
None Documented
Not applicable; Plasma-Lyte 148 contains electrolytes and water that distribute according to body fluid compartments; infusion rate and renal function dictate elimination; clinical context: in normal renal function, excess fluids and electrolytes are cleared with a half-life of approximately 2-4 hours.
Not applicable; composition-dependent. Dextrose half-life ~2 hours. Electrolytes follow endogenous regulation; no terminal elimination half-life defined.
Renal: >90% of infused electrolytes and water are excreted unchanged in urine. Biliary/fecal excretion is negligible (<1%).
Renal 100% (electrolytes and dextrose metabolized to CO2 and water; excess water and electrolytes excreted unchanged in urine).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution